Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Europe’s last maker of key antibiotics ingredients shuts biggest domestic factory
Economy

Europe’s last maker of key antibiotics ingredients shuts biggest domestic factory

Last updated: May 6, 2025 8:10 am
Share
Europe’s last maker of key antibiotics ingredients shuts biggest domestic factory
SHARE

Europe’s last manufacturer of ingredients for some vital antibiotics is closing its biggest domestic factory and shifting some production to China, dealing a blow to Brussels’ efforts to reduce drug dependence on Asia.

Lossmaking Xellia Pharmaceuticals said it could only survive against Chinese competition by moving some of its production to its plant there.

Half of Xellia’s active pharmaceutical ingredients (APIs) feature on the recent EU list of critical medicines and the World Health Organization’s list of essential medicines.

The Danish company told staff on Tuesday that it would shut its Copenhagen plant, resulting in a loss of 500 jobs. For now, it will retain a more cost-efficient European operation in Budapest.

Its chief executive Michael Kocher said that unless government-funded health systems were prepared to pay more for generic medicines, more companies based in the EU would move factories.

“We are discussing so much about reshoring. I think it’s just as important to make sure that what we have in Europe stays in Europe,” he told the Financial Times in an interview.

The medicine ingredients Xellia makes includes vancomycin hydrochloride, which is needed to produce antibiotics that can treat severe infections such as sepsis, which are resistant to other drugs.

About 80 per cent of APIs used in the EU already come from China. With strained health systems unwilling to increase medicine prices, Kocher suggested that subsidies were the only way to ensure the EU retained some control over such important ingredients.

“Otherwise, not just 80 per cent of the APIs will come from China. It will be close to 100 per cent very soon,” he said.

See also  Curiosity rover finds key ingredient for past life on Mars

Western demand for vancomycin hydrochloride could still be met from Budapest if market conditions improved, Kocher stressed.

The European Commission in March unveiled proposals that could be included in a Critical Medicines Act to try to address dependencies exposed by the Covid-19 pandemic, when countries ran short of medicines, protective clothing, and equipment such as ventilators.

These proposals aim to increase EU production of more than 200 medicines, from antibiotics such as penicillin and erythromycin, to painkillers such as lidocaine and morphine.

The measures discussed include allowing countries to join up to make bulk purchases, and favoring EU-made products in procurement processes. But Kocher said the policies were too timid and taking too long to implement.

“Costs are increasing, you try to transfer these costs to your customer and then your customers decide the costs are too high and increase the share coming from China,” he said. “We are seeking a commitment to support ongoing operations.”

Research-intensive pharmaceutical companies have also warned that low prices paid by European health systems are driving new drug discovery efforts to the US and China.

The chief executives of Novartis and Sanofi wrote to the commission last month to call for higher prices. They also pointed out that US tariffs were prompting companies to invest in North America. However, Xellia said it had no plans to do the same.

Xellia, which is owned by Novo Holdings, the controlling shareholder of Danish pharmaceutical powerhouse Novo Nordisk, sells to more than 500 businesses in 80 countries. It will take a decade to slowly transfer production from its Copenhagen factory elsewhere.

See also  Farm antibiotics threat to health

Kocher said the EU should put more value on its “life-saving” products that treat meningitis and other lethal conditions. “Without our product portfolio, we would be faced with a huge challenge. Covid would be a small issue in comparison,” he said.

TAGGED:antibioticsBiggestDomesticEuropesFactoryIngredientsKeymakerShuts
Share This Article
Twitter Email Copy Link Print
Previous Article Wetlands and Streams Face a New Threat from the Trump Administration Wetlands and Streams Face a New Threat from the Trump Administration
Next Article Inflation and the Demand for Money: The Confederacy in the Civil War Inflation and the Demand for Money: The Confederacy in the Civil War
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Ian Freebairn-Smith, Grammy-Winning Composer Who Arranged for ‘A Star Is Born’ and Sang ‘MASH’ Title Song, Dies at 93

Ian Freebairn-Smith, a celebrated Grammy-winning composer known for his arrangement of the song “Evergreen” from…

October 13, 2025

STAT+: FDA aims to expand use of leucovorin as RFK Jr. touts it as autism treatment

Trump and Kennedy Launch New Initiative to Address Autism from the White House Andrew Harnik/Getty…

September 23, 2025

The Endangerment Finding Is in Danger. Will EPA’s Zeldin Uphold Climate Science?

President Trump's Day 1 Executive Order on "unleashing" American (fossil) energy has sparked controversy and…

February 18, 2025

WATCH: White House Holds Emergency Press Conference with Patty Morin, Mother of Rachel Morin, as Media and Democrats Fawn Over Violent El Salvadoran MS-13 Gangster Kilmar Abrego Garcia |

White House Press Secretary Karoline Leavitt is currently conducting a press briefing alongside Patty Morin,…

April 16, 2025

Join SVA MA Curatorial Practice’s Conversations With Curators This Fall

Category: Announcement Distinguished international curators engage in enlightening discussions about pivotal exhibitions and projects in…

September 23, 2025

You Might Also Like

Five key takeaways from Trump’s week in Asia : NPR
World News

Five key takeaways from Trump’s week in Asia : NPR

October 31, 2025
Dan Ives’ AI ETF Hits B in Assets Just Five Months After Launch
Economy

Dan Ives’ AI ETF Hits $1B in Assets Just Five Months After Launch

October 31, 2025
Is This The Best ETF to Invest In Ahead of Potential AI Bubble Burst?
Economy

Is This The Best ETF to Invest In Ahead of Potential AI Bubble Burst?

October 31, 2025
Jay-Z Shuts Down Bad Bunny Super Bowl LX Halftime Show Critics
Lifestyle

Jay-Z Shuts Down Bad Bunny Super Bowl LX Halftime Show Critics

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?